A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events

PloS One
Angela N BrooksMatthew Meyerson


Although recurrent somatic mutations in the splicing factor U2AF1 (also known as U2AF35) have been identified in multiple cancer types, the effects of these mutations on the cancer transcriptome have yet to be fully elucidated. Here, we identified splicing alterations associated with U2AF1 mutations across distinct cancers using DNA and RNA sequencing data from The Cancer Genome Atlas (TCGA). Using RNA-Seq data from 182 lung adenocarcinomas and 167 acute myeloid leukemias (AML), in which U2AF1 is somatically mutated in 3-4% of cases, we identified 131 and 369 splicing alterations, respectively, that were significantly associated with U2AF1 mutation. Of these, 30 splicing alterations were statistically significant in both lung adenocarcinoma and AML, including three genes in the Cancer Gene Census, CTNNB1, CHCHD7, and PICALM. Cell line experiments expressing U2AF1 S34F in HeLa cells and in 293T cells provide further support that these altered splicing events are caused by U2AF1 mutation. Consistent with the function of U2AF1 in 3' splice site recognition, we found that S34F/Y mutations cause preferences for CAG over UAG 3' splice site sequences. This report demonstrates consistent effects of U2AF1 mutation on splicing in distinc...Continue Reading


Oct 25, 1990·Nucleic Acids Research·T D Schneider, R M Stephens
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·P D Zamore, Michael R Green
Mar 3, 2004·Nature Reviews. Cancer·P A FutrealM R Stratton
Jun 3, 2004·Genome Research·Gavin E CrooksSteven E Brenner
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Jul 1, 2006·Science·Luis Miguel Mendes SoaresJuan Valcárcel
Jul 21, 2006·Molecular Biology of the Cell·Teresa Raquel PachecoMaria Carmo-Fonseca
Jan 23, 2009·Nature Cell Biology·Kaylene J SimpsonJoan S Brugge
Mar 18, 2009·Bioinformatics·Cole TrapnellSteven L Salzberg
Jun 10, 2009·Bioinformatics·Heng Li1000 Genome Project Data Processing Subgroup
Sep 24, 2009·Nature Reviews. Molecular Cell Biology·Mo Chen, James L Manley
Feb 4, 2010·Molecular Cell·Laura B Motta-MenaKristen W Lynch
Aug 31, 2010·Nucleic Acids Research·Kai WangJinze Liu
Oct 6, 2010·Genome Research·Angela N BrooksBrenton R Graveley
Sep 13, 2011·Nature·Kenichi YoshidaSeishi Ogawa
Feb 14, 2012·Molecular Cell·Joao Paulo TavanezJuan Valcárcel
Sep 8, 2012·Genome Research·Jennifer HarrowTim J Hubbard
Sep 18, 2012·Cell·Marcin ImielinskiMatthew Meyerson
Sep 25, 2012·Nature·Cancer Genome Atlas Network
Nov 17, 2012·Nucleic Acids Research·Laurence R MeyerW James Kent
Jan 15, 2013·Nature Genetics·J William HarbourAnne M Bowcock
May 3, 2013·The New England Journal of Medicine·Cancer Genome Atlas Research NetworkGreg Eley
May 3, 2013·Nature·Cyriac KandothDouglas A Levine
Jun 19, 2013·Blood·Bartlomiej PrzychodzenHideki Makishima
Sep 4, 2013·Journal of Proteome Research·Yihuang WangHuiru Tang
Sep 28, 2013·Nature Genetics·Cancer Genome Atlas Research NetworkJoshua M Stuart
Sep 28, 2013·Nature Genetics·Travis I ZackRameen Beroukhim


Aug 1, 2014·Nature·Cancer Genome Atlas Research Network
Jan 3, 2015·Frontiers in Biology·Diana Guallar, Jianlong Wang
Jan 15, 2016·Cellular Oncology (Dordrecht)·B SumithraAsim Bikas Das
Jan 20, 2016·Trends in Biochemical Sciences·Nazanine ModjtahediGuido Kroemer
Jan 6, 2016·The Journal of Cell Biology·Benoit Chabot, Lulzim Shkreta
Nov 18, 2015·Current Opinion in Oncology·Cherine Abou FaycalBeatrice Eymin
Jan 21, 2015·Scientific Reports·Jian GuanFabian V Filipp
Apr 22, 2014·Experimental Hematology·Velizar Shivarov, Lars Bullinger
Dec 17, 2014·Immunological Reviews·Christopher N HahnDevendra K Hiwase
Aug 11, 2015·Genome Medicine·Georgina L RylandKylie L Gorringe
Jun 27, 2015·Genome Medicine·Heidi Dvinge, Robert K Bradley
Mar 19, 2015·Annual Review of Biochemistry·Yeon Lee, Donald C Rio
May 3, 2015·Current Hematologic Malignancy Reports·Frank C Kuo, Fei Dong
May 13, 2015·Cancer Cell·Cara Lunn ShiraiMatthew J Walter
May 13, 2015·Cancer Cell·Esther A Obeng, Benjamin L Ebert
Oct 15, 2014·Leukemia·T Okeyo-OwuorTimothy A Graubert
Jun 11, 2016·Nature Reviews. Cancer·Heidi DvingeRobert K Bradley
Aug 23, 2016·Scientific Reports·Chanida VinayanuwattikunGhislaine Scelo
Jan 10, 2017·Nature Communications·Cara Lunn ShiraiMatthew J Walter
Dec 13, 2016·Blood·Borja SaezTimothy A Graubert
Apr 5, 2017·Trends in Genetics : TIG·Jermaine L Jenkins, Clara L Kielkopf
Oct 1, 2014·Genome Research·Janine O IlaganRobert K Bradley
Aug 25, 2016·Molecular Oncology·Fernando J de MiguelRuben Pio
Sep 4, 2017·Human Genetics·Luiz O Penalva, Jeremy R Sanford
Jan 1, 2019·RNA Biology·Urmi DasJiuyong Xie
Feb 19, 2019·Wiley Interdisciplinary Reviews. RNA·Patricia P ColtriGuilherme H G da Silva
Dec 14, 2018·Pharmacological Reviews·Feixiong ChengRuth Nussinov
Feb 29, 2020·International Journal of Molecular Sciences·Toshihiko TakeiwaSatoshi Inoue
Sep 13, 2014·International Journal of Hematology·Katerina Zoi, Nicholas Cp Cross
Aug 18, 2016·RNA·Olga Anczuków, Adrian R Krainer
Jul 24, 2019·Genes, Chromosomes & Cancer·Justin Taylor, Stanley C Lee
Aug 6, 2020·Leukemia·Courtney E HershbergerRichard A Padgett
May 12, 2017·Scientific Reports·Je-Keun RheeTae-Min Kim
Dec 23, 2016·Transcription·Babita Singh, Eduardo Eyras
Apr 25, 2017·The Journal of Clinical Investigation·Bon Ham YipJacqueline Boultwood
Jun 14, 2017·Human Genetics·Fabiana Marcelino MelisoLuiz O Penalva
Sep 20, 2018·F1000Research·Kirsten A Reimer, Karla M Neugebauer
Oct 17, 2018·Proceedings of the National Academy of Sciences of the United States of America·Dennis Liang FeiHarold Varmus
Dec 13, 2019·The Journal of International Medical Research·Bixia LiQitian Mu
Sep 23, 2020·Nature Communications·Hisashi YoshidaEiji Obayashi
Dec 15, 2019·Nature Communications·Mohammad S EsfahaniMaximilian Diehn
Sep 12, 2020·International Journal of Molecular Sciences·Tatiana KováčováLucie Grodecká
Oct 12, 2020·Cell Death & Disease·Pooja PopliRamakrishna Kommagani
Nov 3, 2020·PLoS Biology·Abdalla AkefDaniel R Larson
Feb 1, 2015·Cancer Discovery·Justin ChenWilliam A Weiss
Oct 16, 2019·Cancer Discovery·Esther A ObengOmar Abdel-Wahab
Jul 17, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roch HouotAurélien Marabelle
Mar 24, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Apurva K SrivastavaRalph E Parchment
Sep 9, 2019·Trends in Molecular Medicine·Chi ZhouQi Liu
Dec 15, 2020·International Journal of Laboratory Hematology·Ping ZhangYongmin Tang
Feb 13, 2021·NAR Genomics and Bioinformatics·Shanshan ChengSteven G Rozen

Methods Mentioned


Related Concepts

U2AF1 protein, human
Acute Disease
Carcinoma, Cribriform
HeLa Cells
Leukemia, Monocytic, Chronic
Malignant Neoplasm of Lung
Malignant Neoplasms
Nucleolar Proteins
RNA, Messenger, Splicing

Related Feeds

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
Sug Hyung LeeNam Jin Yoo
Wiley Interdisciplinary Reviews. RNA
Kenichi Yoshida, Seishi Ogawa
© 2021 Meta ULC. All rights reserved